Zavegepant
Overview
Zavegepant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2397415).
API suppliers (1)
Suppliers of Zavegepant evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- MOEHS IBERICA SLSpain1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Zavegepant expires 26 Jun 2034 and exclusivity 9 Mar 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide
- Canonical SMILES
- CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O
- InChIKey
- JJVAPHYEOZSKJZ-JGCGQSQUSA-N
Do you supply Zavegepant? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.